Dibucaine-d9
Product Specifications
UNSPSC Description
Dibucaine-d9 is the deuterium labeled Dibucaine(HY-B0552).Dibucaine (Cinchocaine) is a sodium channel inhibitor. Dibucaine is a potent SChE inhibitor[1][2].
Target Antigen
Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Others
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Smiles
CCN(CC)CCNC(C1=CC(OC([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])=NC2=C1C=CC=C2)=O
Molecular Weight
352.52
References & Citations
[1]Elamin, B., Dibucaine inhibition of serum cholinesterase. J Biochem Mol Biol, 2003. 36(2): p. 149-53.|[2]Souto-Padron, T., A.P. Lima, and O. Ribeiro Rde, Effects of dibucaine on the endocytic/exocytic pathways in Trypanosoma cruzi. Parasitol Res, 2006. 99(4): p. 317-20.|[3]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.
Shipping Conditions
Room temperature
Clinical Information
No Development Reported
CAS Number
98006-44-1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS647252-01 0.1 mg
SULT4A1 (sulfotransferase family 4A, Member 1, Brain sulfotransferase-like protein, Nervous system sulfotransferase, brain sulphotransferase-like, nervous system cytosolic sulfotransferase, sulfotransferase-related protein)
Ask
View Details